
Two Seas Capital LP
About Two Seas Capital LP’s 13F portfolio
Two Seas Capital LP is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Two Seas Capital LP reported $2.5B across 34 US-listed positions (). Its largest position is CALUMET INC (CLMT) at 11% of the reported book, and its ten biggest holdings make up 68% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: CLMT CALUMET INC | $30.32 −4.71% | 11% | 5.3M | $276.6M |
| 2 | NASDAQ: ROIV ROIVANT SCIENCES LTD | $38.73 +0.05% | 11% | 7.3M | $267.9M |
| 3 | NASDAQ: NKTR NEKTAR THERAPEUTICS | $34.42 −4.15% | 8.1% | 3.3M | $202.6M |
| 4 | NASDAQ: CORZ CORE SCIENTIFIC INC NEW | $14.05 +4.00% | 7.3% | 11.4M | $182.6M |
| 5 | OTC: TLN TALEN ENERGY CORP | $360.18 +1.54% | 6.7% | 535K | $167.4M |
| 6 | NASDAQ: IMVT IMMUNOVANT INC | $33.17 −0.12% | 6.2% | 4.6M | $155.8M |
| 7 | NASDAQ: INDV INDIVIOR PHARMACEUTICALS INC | $26.74 −5.21% | 5.2% | 3.7M | $131.6M |
| 8 | NASDAQ: SHC SOTERA HEALTH CO | $16.28 +1.43% | 4.5% | 6.1M | $113.0M |
| 9 | NASDAQ: SHAZ SHARONAI HOLDINGS INC | — — | 4.2% | 1.9M | $106.2M |
| 10 | NYSE: TDAY USA TODAY CO INC | $6.87 −1.72% | 3.6% | 14.5M | $91.2M |
| 11 | NASDAQ: CIFR CIPHER DIGITAL INC | $6.57 +2.34% | 2.7% | 4.4M | $68.9M |
| 12 | NASDAQ: ABVX ABIVAX SA | $83.83 +2.11% | 2.7% | 677K | $67.0M |
| 13 | NASDAQ: FSLR FIRST SOLAR INC | $150.98 −1.30% | 2.6% | 378K | $66.2M |
| 14 | NYSE: SOC SABLE OFFSHORE CORP | $0.60 −8.84% | 2.4% | 17.1M | $59.2M |
| 15 | NASDAQ: GLNG GOLAR LNG LTD | $40.50 −3.43% | 2.3% | 1.2M | $57.1M |
| 16 | NYSE: SEI SOLARIS ENERGY INFRAS INC | $62.72 +1.18% | 2.2% | 787K | $56.0M |
| 17 | NYSE: VST VISTRA CORP | $125.58 −1.23% | 2.1% | 379K | $52.4M |
| 18 | NASDAQ: WULF TERAWULF INC | $12.00 +2.83% | 2.0% | 3.4M | $50.1M |
| 19 | NASDAQ: SATS ECHOSTAR CORP | $89.66 −4.07% | 1.9% | 545K | $48.7M |
| 20 | NASDAQ: QMCO QUANTUM CORP | $13.96 −2.72% | 1.9% | 1.5M | $47.3M |
| 21 | NASDAQ: FTAI FTAI AVIATION LTD | $172.25 −0.01% | 1.8% | 271K | $45.3M |
| 22 | NASDAQ: ABUS ARBUTUS BIOPHARMA CORP | $4.11 +1.48% | 1.6% | 8.1M | $38.9M |
| 23 | NASDAQ: QURE UNIQURE NV | $20.30 −2.31% | 1.3% | 1.3M | $32.0M |
| 24 | TSX: SPCX SPACE EXPLORATION TECHN CORP | $143.50 +1.27% | 1.3% | 209K | $31.5M |
| 25 | NASDAQ: HUT HUT 8 CORP | $57.19 +5.97% | 1.2% | 348K | $30.0M |
Showing 1–25 of 34 positions on this page reported in this 13F.
- Healthcare42%
- Technology15%
- Basic Materials11%
- Energy6.9%
- Communication Services5.6%
- Financial Services3.2%
- Utilities2.1%
- Industrials1.8%
- Real Estate0.1%
- AddedNKTRNEKTAR THERAPEUTICS+8.2%$202.6M
- AddedCORZCORE SCIENTIFIC INC NEW+26.6%$182.6M
- AddedTLNTALEN ENERGY CORP+5.6%$167.4M
- AddedIMVTIMMUNOVANT INC+46.5%$155.8M
- AddedINDVINDIVIOR PHARMACEUTICALS INC+5.5%$131.6M
- AddedSHCSOTERA HEALTH CO+4.7%$113.0M
- AddedSHAZSHARONAI HOLDINGS INC+50.4%$106.2M
- AddedTDAYUSA TODAY CO INC+3.1%$91.2M
- AddedCIFRCIPHER DIGITAL INC+113%$68.9M
- AddedABVXABIVAX SA+177%$67.0M
- ReducedCLMTCALUMET INC−20.2%$276.6M
- ReducedROIVROIVANT SCIENCES LTD−13.6%$267.9M
- ReducedGLNGGOLAR LNG LTD−1.7%$57.1M
- ReducedVSTVISTRA CORP−12.0%$52.4M
- ReducedQMCOQUANTUM CORP−40.1%$47.3M
- ReducedABUSARBUTUS BIOPHARMA CORP−57.4%$38.9M
- ReducedQUREUNIQURE NV−8.1%$32.0M
- SoldIRENIREN LIMITED−100%—
- SoldBTDRBITDEER TECHNOLOGIES GROUP−100%—
- SoldDARDARLING INGREDIENTS INC−100%—
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | OMEX ODYSSEY MARINE EXPLORATION INC | 13D | 10.0% · 2 classes | 5.9M | Filed 13 APR 2026 |
| 2 | NKTR NEKTAR THERAPEUTICS | 13G | 9.8% | 3.3M | Filed 28 SEP 2026 |
| 3 | CLMT Calumet, Inc. | 13G | 9.3% · 2 classes | 8.1M | Filed 17 FEB 2026 |
| 4 | SOC Sable Offshore Corp. | 13G | 9.1% | 18.9M | Filed 16 NOV 2026 |
| 5 | SHAZ SharonAI Holdings Inc. | 13G | 6.6% | 2.5M | Filed 16 NOV 2026 |
| 6 | CORZ Core Scientific, Inc. | 13D | 5.9% | 18.7M | Filed 04 MAR 2026 |
Showing all 6 disclosed stakes.
Reading Two Seas Capital LP’s 13F portfolio
Two Seas Capital LP’s $2.5B 13F book is spread across 34 reported positions and is highly concentrated — its ten largest positions alone are 68% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are CLMT, ROIV, NKTR, CORZ and TLN, led by CALUMET INC (CLMT) at 11% of the portfolio. The heaviest sector exposure is Healthcare (42%), then Technology (15%).
What Two Seas Capital LP changed last quarter
Between 2026-06-30 and Q3 2026, Two Seas Capital LP was a net buyer: it opened 2 new positions and added to 18 more, while trimming 7 and closing 5 outright. Against a 34-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was NEKTAR THERAPEUTICS (NKTR), and its biggest reduction was CALUMET INC (CLMT).
What a 13F does and doesn’t reveal
A 13F captures only Two Seas Capital LP’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Two Seas Capital LP is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Two Seas Capital LP's profile on this page is built directly from those filings.
How current is the 13F data on Two Seas Capital LP's page?
It reflects Two Seas Capital LP's most recently filed 13F, currently the quarter ending Q3 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Two Seas Capital LP files its next quarterly report, this page refreshes automatically.
Can I see Two Seas Capital LP's complete list of holdings?
This page highlights Two Seas Capital LP's largest positions rather than all 34 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Two Seas Capital LP's filings.
Does a 13F show everything Two Seas Capital LP owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Two Seas Capital LP's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Two Seas Capital LP made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

